J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 71,872 shares at $32.61 ($2.4M) on 2022-07-22, disclosed to the SEC on 2022-07-25.
Open-market sale of $2.4M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.54 | 10,829 | $352K | 15.0% |
| 2 | $32.54 | 10,829 | $352K | 15.0% |
| 3 | $33.07 | 19,171 | $634K | 26.9% |
| 4 | $33.07 | 19,171 | $634K | 26.9% |
| 5 | $31.33 | 2,923 | $92K | 3.9% |
| 6 | $31.33 | 2,923 |
| $92K |
| 3.9% |
| 7 | $32.61 | 2,703 | $88K | 3.7% |
| 8 | $32.61 | 2,703 | $88K | 3.7% |
| 9 | $33.28 | 620 | $21K | 0.9% |
| Total | $32.74 avg | 71,872 | $2.4M | 100% |
| Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |
| FATE | SELL | 2022-01-13 | $1.4M | — | Filing → |